Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164528 · ClinicalTrials.gov registry record · Phase 1
Intervening With Children/Adolescents With FAS/ARND
A Phase 1 study of Treatment and Control, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT00164528: Completed Phase 1 study of Treatment and Control, sponsored by Centers for Disease Control and Prevention.
NCT00164528 is a Phase 1 study of Treatment and Control that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 52 participants, below the 172-participant average among 5 other Treatment trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00164528, a Phase 1 study of Treatment and Control, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Children diagnosed through the FAS DPN clinic (who receive non-study services through the clinic/referrals) will receive baseline assessment. The baseline assessment for the child will include: medical issues (including medication), intellectual assessment, academic achievement, language, social functioning, executive functioning, neurological assessment, perceived self-confidence, and behavioral observation of parent-child interactions (videotaped and coded). For caregivers, baseline assessment will include: demographics, medical histories, educational history, current services, satisfaction with services, knowledge of FAS, stress, parenting competence, and family functioning.
Interventions
- BEHAVIORAL Positive Behavior Support
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2001-10 |
| Est. Completion | 2005-06 |
| Phase | Phase 1 |
What the finished NCT00164528 record still lists
NCT00164528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 172-participant average among 5 other Treatment trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Treatment appearing as the primary indexed condition, and to 1 intervention - of which Positive Behavior Support is the first listed.
NCT00164528 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00164528 about?
NCT00164528 is a clinical study titled "Intervening With Children/Adolescents With FAS/ARND". Children diagnosed through the FAS DPN clinic (who receive non-study services through the clinic/referrals) will receive baseline assessment. The baseline assessment for the child will include: medical issues (including medication), intellectual assessment, academic achievement, language, social fun...
What is the current status of trial NCT00164528?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2001-10. Estimated completion is 2005-06.
What conditions does trial NCT00164528 study?
This clinical trial studies the following conditions: Treatment, Control.
What interventions are being tested in trial NCT00164528?
The interventions under investigation include: Positive Behavior Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164528?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00164528 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Treatment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
First in Human Study of TLC-ART 101 (ACTU 2001)
COMPLETED · Phase 1
-
Surgical Approach to Uterine Septum
RECRUITING · NA
-
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
RECRUITING · NA
-
Modulating Exercise Dosage to Improve Concussion Recovery
RECRUITING · Phase 2
-
Brief Acceptance and Commitment Therapy for HIV-infected At-risk Drinkers
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia